tykhr
sign in
free sign up
Hexo Corp
Drug Manufacturers-Specialty & Generic
Healthcare
HEXO
43.00 M shares
NASDAQ US
traded
22 May 2023
listed
yes
open
1.39
52 week high
10.28
high
1.52
52 week low
1.32
low
1.39
growth
-2.05 %
previous Close
1.42
P/E ratio
market cap
65.11 M
div yield
0
usd
Jan 2023
qoq
revenue
24.16 M
-32.46 %
net incoming
722 K
101.28 %
eps
0.00 %
-271.43 %
eps surprise
-18.18 %
net profit margin
2.99 %
160.00 %
operating incoming
-29.75 M
26.59 %
net change in cash
-44.25 M
-830.82 %
cash on hand
34.23 M
-56.38 %
cost of revenue
30.14 M
-43.27 %
top